Contract HT942523C0095
Versiti Blood Health, Inc. · Department Of Defense · August 21, 2024
Versiti Blood Health, Inc. was awarded a federal contract by Department Of Defense (Defense Health Agency) on August 21, 2024 for $1.99 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Milwaukee, WI. It was awarded under full and open competition. It uses cost no fee contract pricing. If all options are exercised, the contract could reach $6.49 million.
Contract details
- PIID
- HT942523C0095
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Milwaukee, WI
- First action
- August 21, 2024
Description
PROPOSAL JOINT WARFIGHTER 220021 - CONTRACT
Modification timeline
-
August 21, 2024Mod P00001 · Supplemental Agreement For Work Within Scope$6.49M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Avian, Llc | Department Of Defense | December 31, 2025 | $54.05M |
| Rtx Bbn Technologies, Inc. | Department Of Defense | December 29, 2025 | $4.36M |
| Council On Strategic Risks (The) | Department Of Defense | December 23, 2025 | $356.6K |
| Eagle Integrated Services, Llc | Department Of Defense | December 23, 2025 | $1.93M |
| Ssi-Venesco Jv Llc | Department Of Defense | December 23, 2025 | $144.5K |
| Techwerks Llc | Department Of Defense | December 23, 2025 | $2.21M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HT942523C0095?
Contract HT942523C0095 is a federal contract awarded to Versiti Blood Health, Inc. by Department Of Defense on August 21, 2024 for $1.99 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract HT942523C0095?
Versiti Blood Health, Inc. won contract HT942523C0095 from Department Of Defense.
How much is contract HT942523C0095 worth?
Contract HT942523C0095 has obligated $1.99 million to date, with a total potential value of $6.49 million if all options are exercised.